BMW to Double Self-Driving Car Testing Fleet

Despite the death of a pedestrian by a self-driving car in Tempe, AZ, BMW will not change its emphasis on researching and producing self-driving vehicles.

Already there are observers blaming the Tempe incident on the negligence of the victim, giving BMW and other developers a rationale for staying the course in R&D for a reputable self-driving vehicle. BMW is set to double the size of its testing fleet to about 80 vehicles in 2018.

Nevertheless, the company still does not plan to launch its vehicle until 2021, believing that the software applications for a self-driving car are still not at the critical standard required to safely process the massive amount of information needed to keep the vehicle efficient and safe.

Yet on the other hand, BMW feels that a budding new era with fleets of self-driving autonomous cars will eventually replace the ride-hailing and car-sharing apps that consumers currently use in the U.S and around the world.

BMW compares the self-driving car venture with a mission to Mars, and that speaks to the seriousness of their R&D effort.

Read more at Reuters

Follow us on social media for the latest updates in B2B!

Image

Latest

Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More
Firefly
Pursuing the Impossible: The New Space Race with Firefly Aerospace Co-Founder Eric Salwan
April 1, 2026

Many companies set out to do something hard. Firefly Aerospace set out to do the impossible. After 10 years and several existential moments, Firefly did what no private company ever had: in 2025, it successfully landed on the Moon. Before Firefly, only countries had ever landed on the Moon—and it took extraordinary national effort…

Read More
internship
Tale of Two Interns: What AI Is Really Doing to Entry-Level Work
March 30, 2026

The narrative around early-career work has become increasingly pessimistic, with headlines pointing to a shrinking pool of entry-level roles, fewer internship opportunities, and AI accelerating both trends. But beneath that narrative, a different tension is emerging—one that’s less about the disappearance of opportunity and more about how it’s being reshaped. Students are using AI…

Read More